Coca-Cola Bottling Co. Consolidated
COKE
$164.98
-4.34%
Coca-Cola Consolidated, Inc. is a major independent bottler and distributor of non-alcoholic beverages in the United States, operating within the Consumer Defensive sector. The company holds a distinct competitive identity as a key strategic partner in The Coca-Cola system, managing a significant territory and serving as a critical link between the brand and consumers. The current investor narrative is shaped by its strong financial performance, including significant revenue growth and robust cash generation, which has driven a substantial stock price appreciation over the past year, positioning it as a standout performer in the stable beverage industry.…
COKE
Coca-Cola Bottling Co. Consolidated
$164.98
Investment Opinion: Should I buy COKE Today?
Rating: Hold. The core thesis is that COKE is a fundamentally strong company with excellent cash flow, but its stock price has run far ahead of itself technically, creating an unfavorable risk/reward profile at current levels near 52-week highs.
Supporting evidence includes a trailing P/E of 19.79x, which is reasonable for its growth, but the forward P/E of 5.24x is the key metric suggesting embedded high expectations. Revenue growth is healthy at 9.03% YoY, and profitability is solid with a 7.89% net margin. The stock's 70.92% 1-year gain and position at 93% of its 52-week range indicate the positive story is largely priced in, leaving limited near-term upside without a significant catalyst.
The two biggest risks are a technical pullback from overbought conditions and the lack of analyst consensus creating valuation uncertainty. This Hold rating would upgrade to a Buy on a pullback to the $170-$180 range (a 10-15% decline), providing a better entry point. It would downgrade to Sell if the stock breaks below key support at $180 on high volume, signaling trend failure. Relative to its own historical P/E range (10.6x to 28x), the stock is fairly valued at 19.79x, but the technical overextension makes it vulnerable in the short term.
Sign up to view all
COKE 12-Month Price Forecast
The AI assessment is neutral based on a clash between strong fundamentals and precarious technicals. The company's financial health is excellent, with accelerating revenue and powerhouse cash generation. However, the stock's price action tells a story of a move that may have gotten ahead of itself, trading near 52-week highs with weakening short-term relative strength. The forward P/E of 5.24x is a tantalizing number but places immense pressure on upcoming earnings to deliver. The stance would upgrade to bullish on a successful breakout above $220 on high volume with confirming earnings, or on a pullback to the $170s that resets the risk/reward. It would downgrade to bearish on a breakdown below $180, which would signal the powerful uptrend has broken.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Bottling Co. Consolidated's 12-month outlook, with a consensus price target around $214.47 and implied upside of +30.0% versus the current price.
Average Target
$214.47
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$132 - $214
Analyst target range
Insufficient analyst coverage available, with data indicating only one analyst providing estimates. This limited coverage is typical for a smaller, regionally-focused bottler like Coca-Cola Consolidated and can lead to less efficient price discovery and higher volatility due to lower institutional scrutiny. The lack of a consensus rating or price target means investors must rely more heavily on their own fundamental and technical analysis when evaluating the stock, as there is minimal sell-side research to provide an external benchmark for valuation or sentiment.
Bulls vs Bears: COKE Investment Factors
The bull case, driven by explosive momentum, strong fundamentals, and a low forward P/E, currently holds stronger evidence given the stock's 70%+ annual return and robust cash generation. However, the bear case presents significant near-term risks from technical overextension and a complete lack of analyst consensus. The single most important tension in the investment debate is whether the stock's powerful price momentum, which has pushed it to the top of its 52-week range, can be sustained in the face of valuation anomalies and the absence of sell-side validation. The resolution hinges on whether upcoming earnings validate the market's implied forward earnings growth or if the stock succumbs to profit-taking after its massive run.
Bullish
- Explosive Price Momentum: The stock has delivered a remarkable +70.92% return over the past year, significantly outperforming the S&P 500's +29.04%. This powerful uptrend, with a +34.11% gain over the last three months, demonstrates strong market conviction and momentum, suggesting a re-rating of the company's prospects.
- Strong Revenue Growth & Profitability: Q4 2025 revenue grew 9.03% year-over-year to $1.904 billion, showing sequential quarterly growth. The company maintains robust profitability with a trailing net margin of 7.89% and generated $620.3 million in trailing free cash flow, indicating high-quality earnings and financial strength.
- Compelling Forward Valuation: The stock trades at a forward P/E of just 5.24x, a significant discount to its trailing P/E of 19.79x. This massive gap implies the market is pricing in a substantial earnings increase, offering a potentially attractive entry point if forward estimates are met.
- Low Market Volatility Profile: With a beta of 0.605, COKE exhibits approximately 40% less volatility than the broader market. This low systematic risk profile is attractive for a stock showing such strong price appreciation, offering a smoother ride for risk-averse investors.
Bearish
- Extreme Technical Overextension: Trading at $203.92, the stock is near the top of its 52-week range ($105.21 to $219.65), sitting at approximately 93% of that range. The recent 1-month relative strength of -8.53% versus the S&P 500 suggests the powerful rally may be exhausting, increasing near-term pullback risk.
- Valuation Anomalies & Accounting Distortions: Key financial ratios are distorted: the negative ROE of -77.1% and negative Debt-to-Equity of -4.06, while likely accounting artifacts, create opacity. The P/B ratio of -15.26 is meaningless, complicating traditional value analysis and potentially masking underlying financial leverage.
- Severe Lack of Analyst Coverage: Only one analyst provides estimates, with no consensus price target or rating available. This minimal sell-side scrutiny leads to less efficient price discovery, higher potential for mispricing, and leaves investors without a critical external benchmark for valuation.
- Revenue Concentration Risk: The Nonalcoholic Beverage segment generated $1.893 billion of the total $1.904 billion Q4 revenue, representing over 99% of sales. This extreme dependence on a single segment and its geographic territory exposes the company to regional economic downturns and shifts in consumer beverage preferences.
COKE Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a 1-year price change of +70.92%. With a current price of $203.92, it is trading at approximately 93% of its 52-week range ($105.21 to $219.65), indicating the stock is near its recent highs and demonstrating strong momentum, though also suggesting potential for overextension. Recent momentum shows acceleration, with a 3-month gain of +34.11%, but a more modest 1-month increase of +1.45%, which may signal a consolidation phase after the sharp run-up; this is corroborated by a negative 1-month relative strength of -8.53% versus the S&P 500. Key technical support is anchored at the 52-week low of $105.21, while immediate resistance is at the 52-week high of $219.65; a decisive breakout above resistance would confirm the bullish trend's continuation. The stock's beta of 0.605 indicates it is approximately 40% less volatile than the broader market, which is notable for a company exhibiting such strong price appreciation and suggests lower systematic risk for investors.
Beta
0.60
0.60x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$105-$220
Price range past year
Annual Return
+43.3%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | -16.9% | +8.2% |
| 3m | +0.8% | +9.0% |
| 6m | +3.4% | +10.5% |
| 1y | +43.3% | +26.5% |
| ytd | +10.1% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue growth is healthy and accelerating, with Q4 2025 revenue of $1.904 billion representing a 9.03% year-over-year increase, and this follows a trend of sequential quarterly revenue growth from $1.580 billion in Q1 to the Q4 figure. The Nonalcoholic Beverage Segment, generating $1.893 billion, is the unequivocal driver, accounting for over 99% of total revenue. The company is highly profitable, with Q4 net income of $137.3 million and a trailing net margin of 7.89%; gross margin for the quarter was a solid 38.21%, though it has shown some quarterly fluctuation between 38.2% and 40.0% over the past year. Profitability is supported by strong cash generation, with trailing twelve-month free cash flow of $620.3 million, yielding a robust FCF margin; the balance sheet shows a current ratio of 1.26, indicating adequate short-term liquidity, but the negative debt-to-equity ratio of -4.06 and negative ROE of -77.1% are accounting anomalies likely due to retained earnings significantly exceeding shareholder equity, rather than indicating financial distress given the strong cash flows.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Given the positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 19.79x and a significantly lower forward PE of 5.24x, with the large gap implying the market expects a substantial increase in earnings over the next year. Compared to sector averages, the trailing PE of 19.79x is reasonable for a company with its growth profile, though direct industry comparison data is not available in the provided set. Historically, the stock's own PE ratio has fluctuated significantly, from a low near 10.6x in early 2023 to over 28x in late 2023; the current level near 20x sits comfortably within this range, suggesting the market is pricing in sustained earnings growth without excessive optimism seen at prior peaks.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is not distress—given strong $620M FCF—but valuation opacity and earnings volatility. The negative ROE (-77.1%) and Debt-to-Equity (-4.06) ratios, while accounting artifacts from retained earnings exceeding equity, distort traditional analysis and could mask underlying leverage. Revenue concentration is extreme, with over 99% from the Nonalcoholic Beverage segment, creating vulnerability to regional economic shocks or a strategic shift by The Coca-Cola Company. Gross margin has fluctuated between 38.2% and 40.0% over recent quarters, indicating potential cost pressure sensitivity.
Market & Competitive Risks: The stock faces significant valuation compression risk after its 70.92% annual surge, trading near 52-week highs. Its low beta of 0.605 suggests it is not a typical high-flyer, making the recent momentum potentially unsustainable if growth expectations moderate. As a regional bottler, it faces competitive risks from national distributors and potential renegotiation of its critical franchise agreement with Coca-Cola. The lack of analyst coverage (only one) exacerbates these risks by reducing institutional scrutiny and liquidity, potentially leading to sharper corrections on negative news.
Worst-Case Scenario: The worst-case involves a simultaneous earnings miss that fails to justify the forward P/E of 5.24x, coupled with a broader market downturn affecting high-momentum stocks. This could trigger a rapid de-rating as the technical overextension unwinds. The realistic downside could see the stock retreat to its 52-week low of $105.21, representing a loss of approximately -48% from the current price of $203.92. A more measured bear case, aligning with the recent max drawdown of -25.34% witnessed in March 2026, suggests a potential decline to the $152-$160 range, a loss of -20% to -25%.
FAQ
The key risks are, in order of severity: 1) Technical/Pullback Risk: The stock is up 70.92% in a year and trades at 93% of its 52-week range, making it vulnerable to profit-taking. The recent -25.34% max drawdown shows this volatility. 2) Earnings & Valuation Risk: The forward P/E of 5.24x implies massive earnings growth; a miss would trigger a sharp de-rating. 3) Analyst & Liquidity Risk: With only one covering analyst, price discovery is less efficient, which can exacerbate swings. 4) Concentration Risk: Over 99% of revenue comes from the Nonalcoholic Beverage segment, creating dependence on a single business line and its geographic territory.
The 12-month forecast is characterized by three scenarios with a neutral base case. The Base Case (55% probability) sees the stock consolidating between $185 and $215 as it digests its massive gains, with earnings meeting high expectations. The Bull Case (25% probability), targeting $219-$240, requires a breakout above all-time highs driven by stellar earnings and a new capital return policy. The Bear Case (20% probability), targeting $150-$175, involves an earnings disappointment triggering a retreat to lower support. The most likely outcome is consolidation (Base Case), as the stock's extreme momentum likely needs time to cool off before establishing a new trend, contingent on the company delivering the growth implied by its forward valuation.
COKE presents a complex valuation picture. Based on trailing earnings, it trades at a P/E of 19.79x, which is reasonable within its own historical range of 10.6x to 28x and for a company with its growth profile. The forward P/E of 5.24x appears deeply undervalued, but this metric embeds extremely high earnings growth expectations that must be validated. Compared to sector averages, its Price-to-Sales ratio of 1.56x is likely moderate. The market is currently paying a fair price for past performance but is demanding (and pricing in) exceptional future growth. Therefore, it is fairly valued on a trailing basis but will be deemed undervalued or overvalued based entirely on whether it meets the aggressive forward earnings implied by its 5.24x multiple.
COKE is a good stock for a specific investor profile at the right price. The company itself is strong, with 9.03% revenue growth, a 7.89% net margin, and $620 million in annual free cash flow. However, after a 70.92% price surge over the past year, the stock is trading near its 52-week high, presenting a poor near-term risk/reward. It is a good buy for long-term, patient investors who believe in the fundamental story and are willing to wait out potential consolidation, or for traders looking to buy on a significant pullback towards the $170-$180 support zone. The lack of analyst coverage adds an element of uncertainty for those reliant on external research.
COKE is more suitable for a medium to long-term investment horizon of 2+ years rather than short-term trading. Its low beta of 0.605 indicates lower volatility aligned with long-term holding, and its business model as a defensive consumer staples bottler provides stability. However, the recent explosive price move and technical overextension suggest short-term traders face high risk of a pullback. Long-term investors can look through this volatility to capture the company's durable cash flows and growth. A minimum holding period of 12-18 months is suggested to allow the current valuation (forward P/E of 5.24x) to play out and for the technical picture to reset, making it a candidate for a core holding in a diversified portfolio rather than a tactical trade.